Skip to main content

Table 1 Patient demographics and overall survival

From: Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma

 

All patients

5 Years OS (%)

10 Years OS (%)

p

Characteristics

No.

Events

Rate

95%CI

Rate

95%CI

Entire cohort

1679

543

64.5

62.1-67.1

61.8

59.2-64.5

 

Age (years)

      

<0.001

0-4

639

173

71.3

67.5-75.2

69.1

65.2-73.2

 

5-9

390

97

73.2

68.5-78.2

68.8

63.6-74.5

 

10-14

346

134

56.4

50.9-62.6

52.4

46.6-59.0

 

15-19

304

139

47.9

42.1-54.6

47.3

41.5-54.0

 

Tumor size (cm)

      

<0.001

0-4

618

116

79.5

76.0-83.1

77.1

73.4-81.1

 

5-9

675

237

61.6

57.7-65.7

57.6

53.5-62.1

 

≥10

386

190

45.9

40.7-51.7

44.4

39.1-50.3

 

Sex

      

0.311

Male

974

306

65.7

62.5-69.1

62.5

59.1-66.1

 

Female

705

237

63.0

59.2-67.0

60.8

56.8-65.0

 

Race

      

0.359

White

1274

407

65.2

62.4-68.1

62.2

59.2-65.3

 

Black

277

88

64.0

58.0-70.7

62.2

55.9-69.2

 

Others

128

48

58.7

50.0-69.0

56.6

47.5-67.5

 

Site

      

<0.001

Unfavorable

1026

406

56.6

53.2-59.9

53.5

50.1-57.1

 

Favorable

653

137

77.1

73.6-80.7

74.6

70.8-78.5

 

Stage

      

<0.001

Localized

561

83

84.0

80.7-87.5

81.1

77.3-85.1

 

Regional

586

152

72.4

68.6-76.5

68.5

64.3-73.1

 

Distant

532

308

35.7

31.5-40.5

34.4

30.1-39.2

 

Histology

      

<0.001

Embryonal

991

249

73.5

70.6-76.5

70.8

67.6-74.1

 

Alveolar

558

263

46.3

41.9-51.2

43.2

38.7-48.3

 

Others

130

31

73.1

64.9-82.3

71.4

62.9-81.0

 

Surgery

      

<0.001

None

686

294

52.0

48.0-56.2

50.4

46.4-54.7

 

Surgery

993

249

73.2

70.2-76.3

69.9

66.3-73.0

 

Radiotherapy

      

0.045

None

625

213

62.7

58.7-67.0

60.8

56.6-65.3

 

Radiation

1054

330

65.6

62.5-68.9

62.3

59.1-65.8

 
  1. OS, overall survival; CI, confidence interval.